查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941881

人体生长荷尔蒙市场规模、份额和趋势分析报告：按产品类型、应用、给药频率、分销管道、地区和细分市场预测（2026-2040 年）

Human Growth Hormone Market Size, Share & Trends Analysis Report By Product Type (Branded Products, Biosimilars), By Application, By Dosing Frequency, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2040
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

人体生长荷尔蒙概述

全球人体生长荷尔蒙市场规模预计2025年达到75.2亿美元，预计2040年将达到284.1亿美元。 2026年至2040年间，该市场预计将以8.52%的复合年增长率成长。人体生长荷尔蒙需求旺盛的主要原因是成人荷尔蒙缺乏症，尤其是生长激素缺乏症（GHD）。据估计，GHD的盛行率约为每万人2-3例。

在成人中，生长激素缺乏症（GHD）可能由脑下垂体肿瘤、脑外伤或自然老龄化过程引起，导致一系列症状，包括肌肉量减少、腹部脂肪堆积、骨骼密度下降、疲劳和代谢紊乱。由于这些症状缺乏特异性，诊断常常被延误，造成了巨大的未满足医疗需求。这种未满足的需求推动了人类生长激素（HGH）疗法的引入，因为患者寻求治疗以改善生活品质、控制代谢併发症并恢復荷尔蒙平衡。儿童生长迟缓，例如GHD引起的矮小症，仍然是人体生长荷尔蒙市场的主要驱动力。

人体生长荷尔蒙给药和製剂方面的技术创新显着提升了市场需求。重组人体生长荷尔蒙（rhGH）的研发已取代传统的萃取方法疗法，实现了更高的纯度、更佳的安全性和更稳定的疗效。这些进步拓展了HGH在儿童生长迟缓和成人荷尔蒙缺乏症治疗中的应用，扩大了患者群体，并提高了整体治疗接受度。长效HGH製剂和缓释注射剂等最新创新透过减少给药频率提高了患者的便利性。这尤其改善了需要持续治疗的成年患者的治疗体验，大大提高了HGH疗法的接受度。此外，自动注射器和预填充注射笔的出现，使注射过程更加轻鬆便捷，从而提升了患者的接受度和满意度。

製剂和给药系统的技术创新是人体生长荷尔蒙市场成长的关键成长要素。专利趋势清晰地表明，市场正朝着温度稳定的製剂、缓释系统以及无痛或非侵入性给药方式发展。所有这些发展旨在减轻治疗负担、提高患者依从性并消除每日註射带来的不便，最终带来更好的临床疗效和更高的市场接受度。

专利反映出的一个总体趋势是，研发投入不断增加，旨在将人类生长激素（HGH）疗法从每日註射转变为长效、便捷且技术更先进的製剂。这些创新技术的商业化有望透过提高用药依从性、减轻治疗负担以及支持高价策略，进一步扩大市场渗透率。随着无针给药方法、缓释系统、微针平台和高稳定性製剂的持续发展，技术将继续成为人体生长荷尔蒙市场的主要竞争驱动力。诸如EasyPod自动电子注射器等创新给药系统的推出，显着促进了人体生长荷尔蒙疗法更易于获得且更有效，并支持市场扩张。

目录

第一章：调查方法和范围

第二章执行摘要

第三章：人体生长荷尔蒙市场的变数、趋势与范围

  • 市场谱系展望
  • 市场动态
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章：人体生长荷尔蒙市场：依产品类型分類的商业分析

  • 按产品类型分類的市场份额（2025 年和 2040 年）
  • 按产品类型分類的市场规模、预测和趋势分析（2021-2040 年）
  • 品牌产品
  • 生物相似药

第五章：人体生长荷尔蒙市场：按应用领域分類的商业分析

  • 按应用领域分類的市场份额（2025 年和 2040 年）
  • 按应用领域分類的市场规模、预测与趋势分析（2021年至2040年）
  • 生长激素缺乏症（GHD）
  • 透纳氏症
  • 原发性矮小症
  • 普拉德-威利症候群
  • 相对于胎龄而言的低出生体重（SGA）
  • 其他迹象

第六章：人体生长荷尔蒙市场：依给药频率分類的业务分析

  • 按给药频率分類的市场份额（2025 年和 2040 年）
  • 按给药频率分類的市场规模、预测和趋势分析（2021-2040 年）
  • 每日註射生长激素
  • 每週注射一次生长激素

第七章：人体生长荷尔蒙市场：按分销管道分類的业务分析

  • 按分销管道分類的市场份额（2025 年和 2040 年）
  • 按分销管道分類的市场规模、预测和趋势分析（2021-2040 年）
  • 医院药房
  • 零售药房
  • 网路药房
  • 专科药房

第八章：人体生长荷尔蒙市场：区域估算与趋势分析

  • 区域市场占有率分析（2025 年和 2040 年）
  • 区域市场概览
  • 2021年至2040年市场规模及预测趋势分析：
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 参与公司概况
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/列表
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Ascendis Pharma A/S
    • Sandoz International GmbH（Novartis）
    • Merck KGaA/EMD Serono
    • Eli Lilly and Company
    • Ferring Pharmaceuticals
    • GeneScience Pharmaceuticals
    • Anhui Anke Biotechnology
    • LG Chem
Product Code: GVR-2-68038-057-6

Human Growth Hormone Summary

The global human growth hormone market size was estimated at USD 7.52 billion in 2025 and is projected to reach USD 28.41 billion by 2040, growing at a CAGR of 8.52% from 2026 to 2040. The main reason for the high demand of human growth hormone is adult hormone deficiency, especially Growth Hormone Deficiency (GHD). The estimated prevalence of GHD is approximately 2-3:10,000 population.

In adults, GHD may be caused by pituitary tumors, traumas to the brain, or natural aging processes, which in turn, produce a series of symptoms such as the loss of muscle mass, the distribution of fat towards the abdomen, decreased bone density, lethargy, and metabolic disturbances. The non-specific nature of these symptoms often delays diagnosis, creating a significant unmet medical need. This unmet need drives the adoption of HGH therapy, as patients seek treatment to improve quality of life, manage metabolic complications, and restore hormonal balance. Growth disorders in children, such as short stature due to GHD, remain a foundational driver of the human growth hormone market.

Technological innovations in human growth hormone delivery and formulation have significantly boosted market demand. The development of recombinant human growth hormone (rhGH) has replaced older extraction-based therapies, offering higher purity, improved safety, and consistent efficacy. These advances have expanded the therapeutic application of HGH in both pediatric growth disorders and adult hormone deficiencies, creating a larger patient base and increasing overall treatment adoption. Recent innovations such as long-acting HGH formulations and sustained-release injections have improved patient convenience by reducing the frequency of administration. The situation is improved for the patients, especially for the adults who need continuous treatment. Thus, the acceptance of HGH therapies is growing to a larger extent. Moreover, the auto-injectors and pre-filled pens have contributed to making the process of injections less painful and friendly, which in turn has positively affected the patients' acceptance and satisfaction.

The technological innovation regarding the formulation and delivery systems has been a significant growth driver in the Human Growth Hormone market. Patent activity clearly indicates a transformation towards temperature-stable formulations, sustained-release systems, and painless or non-invasive delivery methods. All these developments are intended to decrease the burden of treatment, boost patient adherence, and eliminate the daily injection-related difficulties, which in turn will lead to better clinical results and higher market acceptance.

The general trend reflected in the patents is that there is an increasing amount of R&D aimed at the transition of HGH therapy from daily injections to long-lasting, user-friendly, and technologically superior formats. The commercialization of these innovations will likely result in deeper market penetration through adherence enhancement, treatment burden reduction, and premium pricing support. The market of human growth hormones will continue to be driven by technology as the major competitive factor due to the ongoing developments in needle-free delivery, sustained-release systems, microneedle platforms, and high-stability formulations. The introduction of innovative delivery systems, such as the Easypod, an automated electronic injection device for growth hormone administration, has significantly contributed to the growth of the Human Growth Hormone market. These devices simplify the injection process, save patients' time, and reduce the risk of dosing errors, as the correct dose is programmed and verified by a healthcare professional. Such technological advancements enhance patient adherence and convenience, making HGH therapy more accessible and effective, thereby supporting market expansion.

Global Human Growth Hormone Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2040. For this study, Grand View Research has segmented the global human growth hormone market report based on product type, application, dosing frequency, distribution channel, and region:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2040)
  • Branded Products
    • Norditropin
    • Sogroya
    • Skytrofa
    • Ngenla
    • Other
  • Biosimilars
  • Application Outlook (Revenue, USD Million, 2021 - 2040)
  • Growth Hormone Deficiency (GHD)
    • Adult Growth Hormone Deficiency
    • Pediatric Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Small for Gestational Age (SGA)
  • Other Indications
  • Dosing Frequency Outlook (Revenue, USD Million, 2021 - 2040)
  • Daily hGH Injection
  • Weekly hGH Injection
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2040)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy
  • Regional Outlook (Revenue, USD Million, 2021 - 2040)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Application
    • 1.2.3. Dosing Frequency
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Human Growth Hormone Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Human Growth Hormone Market: Product Type Business Analysis

  • 4.1. Product Type Market Share, 2025 & 2040
  • 4.2. Product Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2021 to 2040 (USD Million)
  • 4.4. Branded Products
    • 4.4.1. Branded Products Market, 2021 - 2040 (USD Million)
    • 4.4.2. Norditropin
      • 4.4.2.1. Norditropin Market, 2021 - 2040 (USD Million)
    • 4.4.3. Sogroya
      • 4.4.3.1. Sogroya Market, 2021 - 2040 (USD Million)
    • 4.4.4. Skytrofa
      • 4.4.4.1. Skytrofa Market, 2021 - 2040 (USD Million)
    • 4.4.5. Ngenla
      • 4.4.5.1. Ngenla Market, 2021 - 2040 (USD Million)
    • 4.4.6. Other
      • 4.4.6.1. Other Market, 2021 - 2040 (USD Million)
  • 4.5. Biosimilars
    • 4.5.1. Biosimilars Market, 2021 - 2040 (USD Million)

Chapter 5. Human Growth Hormone Market: Application Business Analysis

  • 5.1. Application Market Share, 2025 & 2040
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2040 (USD Million)
  • 5.4. Growth Hormone Deficiency (GHD)
    • 5.4.1. Growth Hormone Deficiency (GHD) Market, 2021 - 2040 (USD Million)
    • 5.4.2. Adult Growth Hormone Deficiency
      • 5.4.2.1. Adult Growth Hormone Deficiency, 2021 - 2040 (USD Million)
    • 5.4.3. Pediatric Growth Hormone Deficiency
      • 5.4.3.1. Pediatric Growth Hormone Deficiency, 2021 - 2040 (USD Million)
  • 5.5. Turner Syndrome
    • 5.5.1. Turner Syndrome Market, 2021 - 2040 (USD Million)
  • 5.6. Idiopathic Short Stature
    • 5.6.1. Idiopathic Short Stature Market, 2021 - 2040 (USD Million)
  • 5.7. Prader-Willi Syndrome
    • 5.7.1. Prader-Willi Syndrome Market, 2021 - 2040 (USD Million)
  • 5.8. Small for Gestational Age (SGA)
    • 5.8.1. Small for Gestational Age (SGA) Market, 2021 - 2040 (USD Million)
  • 5.9. Other Indications
    • 5.9.1. Other Indications Market, 2021 - 2040 (USD Million)

Chapter 6. Human Growth Hormone Market: Dosing Frequency Business Analysis

  • 6.1. Dosing Frequency Market Share, 2025 & 2040
  • 6.2. Dosing Frequency Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Dosing Frequency, 2021 to 2040 (USD Million)
  • 6.4. Daily hGH Injection
    • 6.4.1. Daily hGH Injection Market, 2021 - 2040 (USD Million)
  • 6.5. Weekly hGH Injection
    • 6.5.1. Weekly hGH Injection Market, 2021 - 2040 (USD Million)

Chapter 7. Human Growth Hormone Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2040
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2040 (USD Million)
  • 7.4. Hospital Pharmacy
    • 7.4.1. Hospital Pharmacy Market, 2021 - 2040 (USD Million)
  • 7.5. Retail Pharmacy
    • 7.5.1. Retail Pharmacy Market, 2021 - 2040 (USD Million)
  • 7.6. Online Pharmacy
    • 7.6.1. Online Pharmacy Market, 2021 - 2040 (USD Million)
  • 7.7. Specialty Pharmacy
    • 7.7.1. Specialty Pharmacy Market, 2021 - 2040 (USD Million)

Chapter 8. Human Growth Hormone Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2040
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2040:
  • 8.4. North America
    • 8.4.1. North America Human Growth Hormone Market Estimates and Forecasts, By Country, 2021 - 2040 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Product Type Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Product Type Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. U.S. Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Product Type Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Product Type Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. Uk Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Product Type Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Product Type Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Product Type Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Product Type Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Product Type Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Product Type Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Product Type Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Product Type Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Product Type Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Product Type Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Product Type Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Product Type Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Product Type Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Product Type Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Japan Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Product Type Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. China Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Product Type Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Product Type Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Product Type Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Product Type Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Human Growth Hormone Market Estimates and Forecasts, 2021 - 2040 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Novo Nordisk A/S
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Pfizer Inc.
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Ascendis Pharma A/S
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Sandoz International GmbH (Novartis)
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Merck KGaA / EMD Serono
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Eli Lilly and Company
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Ferring Pharmaceuticals
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. GeneScience Pharmaceuticals
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Anhui Anke Biotechnology
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. LG Chem
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Growth Hormone market, by region, 2021 - 2040 (USD Million)
  • Table 4 Global Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 5 Global Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 6 Global Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 7 Global Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 8 North America Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 9 North America Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 10 North America Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 11 North America Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 12 North America Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 13 U.S. Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 14 U.S. Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 15 U.S. Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 16 U.S. Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 17 Canada Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 18 Canada Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 19 Canada Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 20 Canada Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 21 Mexico Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 22 Mexico Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 23 Mexico Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 24 Mexico Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 25 Europe Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 26 Europe Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 27 Europe Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 28 Europe Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 29 Europe Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 30 UK Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 31 UK Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 32 UK Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 33 UK Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 34 Germany Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 35 Germany Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 36 Germany Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 37 Germany Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 38 France Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 39 France Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 40 France Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 41 France Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 42 Italy Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 43 Italy Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 44 Italy Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 45 Italy Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 46 Spain Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 47 Spain Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 48 Spain Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 49 Spain Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 50 Norway Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 51 Norway Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 52 Norway Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 53 Norway Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 54 Denmark Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 55 Denmark Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 56 Denmark Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 57 Denmark Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 58 Sweden Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 59 Sweden Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 60 Sweden Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 61 Sweden Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 62 Asia Pacific Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 63 Asia Pacific Human Growth Hormone market, by product type, 2021 - 2040 (USD
  • Table 64 Asia Pacific Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 65 Asia Pacific Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 66 Asia Pacific Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 67 Japan Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 68 Japan Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 69 Japan Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 70 Japan Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 71 China Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 72 China Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 73 China Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 74 China Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 75 India Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 76 India Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 77 India Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 78 India Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 79 Australia Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 80 Australia Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 81 Australia Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 82 Australia Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 83 South Korea Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 84 South Korea Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 85 South Korea Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 86 South Korea Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 87 Thailand Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 88 Thailand Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 89 Thailand Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 90 Thailand Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 91 Latin America Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 92 Latin America Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 93 Latin America Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 94 Latin America Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 95 Latin America Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 96 Brazil Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 97 Brazil Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 98 Brazil Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 99 Brazil Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 100 Argentina Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 101 Argentina Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 102 Argentina Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 103 Argentina Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 104 Middle East & Africa Human Growth Hormone market, by country, 2021 - 2040 (USD Million)
  • Table 105 Middle East & Africa Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 106 Middle East & Africa Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 107 Middle East & Africa Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 108 Middle East & Africa Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 109 South Africa Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 110 South Africa Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 111 South Africa Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 112 South Africa Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 113 Saudi Arabia Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 114 Saudi Arabia Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 115 Saudi Arabia Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 116 Saudi Arabia Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 117 UAE Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 118 UAE Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 119 UAE Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 120 UAE Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)
  • Table 121 Kuwait Human Growth Hormone market, by product type, 2021 - 2040 (USD Million)
  • Table 122 Kuwait Human Growth Hormone market, by application, 2021 - 2040 (USD Million)
  • Table 123 Kuwait Human Growth Hormone market, by dosing frequency, 2021 - 2040 (USD Million)
  • Table 124 Kuwait Human Growth Hormone market, by distribution channel, 2021 - 2040 (USD Million)

List of Figures

  • Fig. 1 Human Growth Hormone market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Human Growth Hormone market dynamics
  • Fig. 11 Human Growth Hormone market: Porter's five forces analysis
  • Fig. 12 Human Growth Hormone market: PESTLE analysis
  • Fig. 13 Product Type market, 2021 - 2040 (USD Million)
  • Fig. 14 Branded Products market, 2021 - 2040 (USD Million)
  • Fig. 15 Norditropin market, 2021 - 2040 (USD Million)
  • Fig. 16 Sogroya market, 2021 - 2040 (USD Million)
  • Fig. 17 Skytrofa market, 2021 - 2040 (USD Million)
  • Fig. 18 Ngenlamarket, 2021 - 2040 (USD Million)
  • Fig. 19 Other market, 2021 - 2040 (USD Million)
  • Fig. 20 Biosimilars market, 2021 - 2040 (USD Million)
  • Fig. 21 Application market, 2021 - 2040 (USD Million)
  • Fig. 22 Growth Hormone Deficiency (GHD) market, 2021 - 2040 (USD Million)
  • Fig. 23 Adult Growth Hormone Deficiency market, 2021 - 2040 (USD Million)
  • Fig. 24 Pediatric Growth Hormone Deficiency market, 2021 - 2040 (USD Million)
  • Fig. 25 Turner Syndrome market, 2021 - 2040 (USD Million)
  • Fig. 26 Idiopathic Short Stature market, 2021 - 2040 (USD Million)
  • Fig. 27 Prader-Willi Syndrome market, 2021 - 2040 (USD Million)
  • Fig. 28 Small for Gestational Age (SGA) market, 2021 - 2040 (USD Million)
  • Fig. 29 Other Indications market, 2021 - 2040 (USD Million)
  • Fig. 30 Dosing Frequency market, 2021 - 2040 (USD Million)
  • Fig. 31 Daily hGH Injection market, 2021 - 2040 (USD Million)
  • Fig. 32 Weekly hGH Injection market, 2021 - 2040 (USD Million)
  • Fig. 33 Distribution Channel market, 2021 - 2040 (USD Million)
  • Fig. 34 Hospital Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 35 Retail Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 36 Online Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 37 Specialty Pharmacy market, 2021 - 2040 (USD Million)
  • Fig. 38 Human Growth Hormone market revenue, by region
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 North America Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 41 U.S. country dynamics
  • Fig. 42 U.S. Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 43 Canada country dynamics
  • Fig. 44 Canada Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 45 Mexico country dynamics
  • Fig. 46 Mexico Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 47 Europe Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 48 UK country dynamics
  • Fig. 49 UK Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 50 Germany country dynamics
  • Fig. 51 Germany Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 52 France country dynamics
  • Fig. 53 France Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 54 Italy country dynamics
  • Fig. 55 Italy Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 56 Spain country dynamics
  • Fig. 57 Spain Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 58 Norway country dynamics
  • Fig. 59 Norway Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 64 Asia Pacific Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 65 Japan country dynamics
  • Fig. 66 Japan Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 67 China country dynamics
  • Fig. 68 China Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 69 India country dynamics
  • Fig. 70 India Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 71 Australia country dynamics
  • Fig. 72 Australia Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 73 South Korea country dynamics
  • Fig. 74 South Korea Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 75 Thailand country dynamics
  • Fig. 76 Thailand Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 77 Latin America Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 78 Brazil country dynamics
  • Fig. 79 Brazil Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 80 Argentina country dynamics
  • Fig. 81 Argentina Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 82 MEA Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 83 South Africa country dynamics
  • Fig. 84 South Africa Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 85 Saudi Arabia country dynamics
  • Fig. 86 Saudi Arabia Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 87 UAE country dynamics
  • Fig. 88 UAE Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 89 Kuwait country dynamics
  • Fig. 90 Kuwait Human Growth Hormone market, 2021 - 2040 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Company market position analysis
  • Fig. 93 Strategic framework